APA (7th ed.) Citation

She, J., Chen, X., Iyengar, M., & Li, J. (2026). Evaluation of Minimal Residual Disease as a Surrogate for Progression-Free Survival in Hematology Oncology Trials: A Meta-Analytic Review.

Chicago Style (17th ed.) Citation

She, Jane, Xiaofei Chen, Malini Iyengar, and Judy Li. Evaluation of Minimal Residual Disease as a Surrogate for Progression-Free Survival in Hematology Oncology Trials: A Meta-Analytic Review. 2026.

MLA (9th ed.) Citation

She, Jane, et al. Evaluation of Minimal Residual Disease as a Surrogate for Progression-Free Survival in Hematology Oncology Trials: A Meta-Analytic Review. 2026.